Who makes 250 ppm F as MFP?

250 ppm F as MFP is developed by Procter and Gamble.

What development phase is 250 ppm F as MFP in?

250 ppm F as MFP is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

250 ppm F as MFP

Procter and Gamble · FDA-approved active Small molecule Quality 3/100

At a glance

Generic name	250 ppm F as MFP
Sponsor	Procter and Gamble
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Salivary Fluoride Clearance (PHASE1)
Evaluation of the Fluoride Dose Response Using In Situ Caries Model (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

250 ppm F as MFP CI brief — competitive landscape report
250 ppm F as MFP updates RSS · CI watch RSS
Procter and Gamble portfolio CI